A systematic literature review and meta-analysis on the efficacy and safety of PD-(L)1 inhibitors for the first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer in Asian and non-Asian patients.
Saved in:
| Title: | A systematic literature review and meta-analysis on the efficacy and safety of PD-(L)1 inhibitors for the first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer in Asian and non-Asian patients. |
|---|---|
| Authors: | Girard N; Versailles Saint Quentin University, Paris, France.; Medical Oncology Department, Curie-Montsouris Thorax Institute, Institut Curie, Paris, France., Tan D; National Cancer Centre, Singapore, Singapore., Cortinovis D; SC Medical Oncology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; Department of Medicine, University of Milano-Bicocca, Milan, Italy., Lopes G; Sylvester Comprehensive Cancer Center at the University of Miami and the Miller School of Medicine, Miami, FL, USA., Voon PJ; Sarawak General Hospital, Kuching, Sarawak, Malaysia., Taylor MA; BeOne Medicines, Ltd., Cambridge, MA, USA., Ghali N; BeOne Medicines, Ltd., Cambridge, MA, USA., Zhan L; BeOne Medicines, Ltd., Cambridge, MA, USA., Xu S; BeOne Medicines, Ltd., Shanghai, China., Naicker K; BeOne Medicines, Ltd., London, UK., Peters S; University of Lausanne and University Hospital of Vaud, Lausanne, Switzerland. |
| Source: | Translational lung cancer research [Transl Lung Cancer Res] 2025 Dec 31; Vol. 14 (12), pp. 5305-5322. Date of Electronic Publication: 2025 Dec 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101646875 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2218-6751 (Print) Linking ISSN: 22186751 NLM ISO Abbreviation: Transl Lung Cancer Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2218-6751 |
|---|---|
| DOI: | 10.21037/tlcr-2025-746 |
